Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Chronic inflammatory demyelinating polyneuropathy associated with carcinoma.

Literature DB >> 8708651

Chronic inflammatory demyelinating polyneuropathy associated with carcinoma.

J C Antoine¹, J F Mosnier, J Lapras, P Convers, L Absi, B Laurent, D Michel.

Abstract

The association of chronic inflammatory demyelinating polyneuropathy (CIDP) and carcinoma has rarely been reported and its relevance is debated. Thirty three consecutive patients with probable or definite CIDP (idiopathic or associated with M protein) were investigated. Three patients with definite CIDP had a concomitant carcinoma. One had an IgM paraprotein. Steroids and intravenous immunoglobulins were effective.

Entities: Chemical Disease Species

Mesh：

Year: 1996 PMID： 8708651 PMCID： PMC1073802 DOI： 10.1136/jnnp.60.2.188

Source DB: PubMed Journal: J Neurol Neurosurg Psychiatry ISSN： 0022-3050 Impact factor: 10.154

9 in total

1. Antibodies to acidic glycolipids in Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy.

Authors: A A Ilyas; F A Mithen; M C Dalakas; Z W Chen; S D Cook
Journal: J Neurol Sci Date: 1992-01 Impact factor: 3.181

2. Guillain-Barré syndrome and Hodgkin's disease: three cases with immunological studies.

Authors: R P Lisak; M Mitchell; B Zweiman; E Orrechio; A K Asbury
Journal: Ann Neurol Date: 1977-01 Impact factor: 10.422

3. Peripheral neuropathy of sensorimotor type associated with malignant disease.

Authors: P B Croft; H Urich; M Wilkinson
Journal: Brain Date: 1967-03 Impact factor: 13.501

Review 4. Paraneoplastic neuropathies.

Authors: F Graus; R Reñé
Journal: Eur Neurol Date: 1993 Impact factor: 1.710

5. Demyelinating neuropathies triggered by melanoma immunotherapy.

Authors: G N Fuller; J M Spies; J D Pollard; J G McLeod
Journal: Neurology Date: 1994-12 Impact factor: 9.910

6. Chronic relapsing polyneuritis.

Authors: J W Prineas; J G McLeod
Journal: J Neurol Sci Date: 1976-04 Impact factor: 3.181

7. Prognosis in Guillain-Barré syndrome.

Authors: J B Winer; R A Hughes; R J Greenwood; G D Perkin; M J Healy
Journal: Lancet Date: 1985-05-25 Impact factor: 79.321

8. Paraneoplastic anti-Purkinje and type I anti-neuronal nuclear autoantibodies bind selectively to central, peripheral, and autonomic nervous system cells.

Authors: H J Altermatt; M Rodriguez; B W Scheithauer; V A Lennon
Journal: Lab Invest Date: 1991-10 Impact factor: 5.662

Review 9. Susceptible loci associated with autoimmune disease as potential biomarkers for checkpoint inhibitor-induced immune-related adverse events.

Authors: Esmée P Hoefsmit; Elisa A Rozeman; John B A G Haanen; Christian U Blank
Journal: ESMO Open Date: 2019-07-21

9 in total

Chronic inflammatory demyelinating polyneuropathy associated with carcinoma.

1. Antibodies to acidic glycolipids in Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy.

2. Guillain-Barré syndrome and Hodgkin's disease: three cases with immunological studies.

3. Peripheral neuropathy of sensorimotor type associated with malignant disease.

Review 4. Paraneoplastic neuropathies.

5. Demyelinating neuropathies triggered by melanoma immunotherapy.

6. Chronic relapsing polyneuritis.

7. Prognosis in Guillain-Barré syndrome.

8. Paraneoplastic anti-Purkinje and type I anti-neuronal nuclear autoantibodies bind selectively to central, peripheral, and autonomic nervous system cells.

9. Immunoreactive myelin basic protein in tumor cells associated with carcinomatous neuropathy.

1. Hepatocellular carcinoma presenting with chronic inflammatory demyelinating polyradiculoneuropathy.

Review 2. Immunological mechanisms in paraneoplastic peripheral neuropathy.

3. Chronic idiopathic demyelinating polyneuropathy (CIDP) associated with Kaposi's sarcoma.

4. [Chronic paraneoplastic inflammatory demyelinating polyradiculoneuritis secondary to nasal natural killer lymphoma].

5. Carcinoma associated paraneoplastic peripheral neuropathies in patients with and without anti-onconeural antibodies.

6. Recommended diagnostic criteria for paraneoplastic neurological syndromes.

Review 7. Association between chronic inflammatory demyelinating polyneuropathy and gastrointestinal malignancies.

8. A case of paraneoplastic demyelinating motor polyneuropathy.

Review 9. Susceptible loci associated with autoimmune disease as potential biomarkers for checkpoint inhibitor-induced immune-related adverse events.